Despite the range of available antihyperglycemic therapies, 57%–68% of Chinese patients with T2D fail to attain glycated hemoglobin A1c (HbA1c) target levels of <7.0%. Since PPG levels have better ...

INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...

INDIANAPOLIS, Ind.– Indianapolis-based Eli Lilly and Company announced plans Tuesday to offer two of its insulin pens for half the cost of the branded versions. The two pens will be lower-priced ...

With drugmakers facing renewed calls to lower the cost of prescription drugs, Eli Lilly has taken preemptive action, dropping the cost of its generic insulin by 40%. Starting next year, Lilly’s list ...

INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

Eli Lilly and Company has announced the launch of a lower-priced version of its lispro (Humalog) insulin in the United States. The new version is an "authorized generic" called Insulin Lispro. It will ...

Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...

Nine months after announcing that it will make a half-priced version of one of its liquid insulins, Eli Lilly and Co. has said it will offer less expensive versions of two of its popular insulin pens, ...

Lilly has expanded its insulin affordability options for people with diabetes available through the Lilly Diabetes Solution Center. The Lilly Insulin Value Program allows anyone with commercial ...

Despite the extensive recent focus on its cost, insulin use in the United States remains dominated by insulin glargine and other analogs, as well as pen devices for delivery, new research shows. The ...

Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The ...

(CNN) -- Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of ...